NORAD and breast cancer: Our results pointed out NORAD as the most relevant LncRNA with PUMILIO binding site in breast cancer, differently expressed between Lum A and Basal-like subtypes and co-expressed significantly in Basal-like (0.55) with the RALGAPB gene, a target gene of PUMILIO, related to chromosome stability during cell division.